Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Huapont Life Science Co's PB Ratio or its related term are showing as below:
SZSE:002004'
s PB Ratio Range Over the Past 10 Years
Min: 0.73 Med: 1.07 Max: 2.08
Current: 0.86
During the past 13 years, Huapont Life Science Co's highest PB Ratio was 2.08. The lowest was 0.73. And the median was 1.07.
SZSE:002004's PB Ratio is ranked better than 74.6% of 248
companies
in the Agriculture industry
Industry Median: 1.465
vs SZSE:002004: 0.86
During the past 12 months, Huapont Life Science Co's average Book Value Per Share Growth Rate was 3.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 0.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Huapont Life Science Co was 62.20% per year. The lowest was -2.60% per year. And the median was 20.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Huapont Life Science Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huapont Life Science Co PB Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Huapont Life Science Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Huapont Life Science Co (SZSE:002004) has a PB Ratio of 0.51 as of Sep. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Huapont Life Science Co and its competitors. This is 52% below median its historical median of 1.07. Over the past decade, Huapont Life Science Co's PB Ratio has ranged from 0.73 to 2.08. According to the industry distribution chart, Huapont Life Science Co ranks #63 out of 248 companies in the Agriculture industry, placing it in the top 25.4%.
Is Huapont Life Science Co's PB Ratio too high?
Huapont Life Science Co's current PB Ratio of 0.51 is 52% below median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.08. The Agriculture industry median PB Ratio is 1.47. Huapont Life Science Co's value of 0.51 is 65.2% below this industry median. Based on the distribution chart, Huapont Life Science Co ranks #63 out of 248 companies in the Agriculture industry, which is above the industry midpoint. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's PB Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Huapont Life Science Co ranks #63 out of 248 companies for PB Ratio. This puts Huapont Life Science Co in the upper half of its industry. The industry median PB Ratio is 1.47. Huapont Life Science Co's value of 0.51 is 65.2% below this benchmark. Historically, Huapont Life Science Co's own PB Ratio has ranged from 0.73 to 2.08 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 1.47, Huapont Life Science Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Agriculture company?
The median PB Ratio among Agriculture companies is 1.47, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huapont Life Science Co's current PB Ratio of 0.51 is 65.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Huapont Life Science Co and its competitors. For the Agriculture industry, the median PB Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huapont Life Science Co's current PB Ratio is 0.51, which is 52% below median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current PB Ratio is 0.51, which is 52% below median its 10-year median of 1.07 and 65.2% below the Agriculture industry median of 1.47. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current PB Ratio is 0.51 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
PB Ratio: 0.51 (52% below median its 10-year median of 1.07)
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
Industry Position: 65.2% below the Agriculture median (#63 of 248)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
